Diabetes and dementia: Clinical perspective, innovation, knowledge gaps

Area of Science:

• Neuroscience
• Endocrinology
• Public Health

Background:

• Global rise in type 2 diabetes and dementia presents a significant public health challenge.
• Dementia risk is linked to metabolic conditions like type 2 diabetes, obesity, and metabolic syndrome.
• Type 2 diabetes is a modifiable risk factor for dementia, but the role of anti-diabetic drugs remains unclear.

Purpose of the Study:

• To review the current understanding of the relationship between type 2 diabetes and dementia risk.
• To identify critical knowledge gaps concerning this association.
• To propose strategies and recommendations for mitigating dementia risk in individuals with type 2 diabetes.

Main Methods:

• Literature review of studies examining type 2 diabetes and dementia risk.
• Analysis of key concepts and existing evidence.
• Identification of research gaps and potential solutions.

Main Results:

• Type 2 diabetes is confirmed as a significant risk factor for dementia.
• Evidence on whether anti-diabetic medications reduce dementia risk is currently insufficient.
• A critical knowledge gap exists regarding the direct impact of diabetes management on dementia prevention.

Conclusions:

• Type 2 diabetes management is crucial for potentially reducing dementia risk.
• Further research is needed to clarify the efficacy of anti-diabetic drugs in dementia prevention.
• Recommendations are provided to address knowledge gaps and mitigate risks associated with type 2 diabetes and dementia.